← Leaderboards
Donald J Buchsbaum
University Of Alabama At Birmingham
$5,699,601
Attributed
$5,893,524
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2010–21$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$16,991,024 · 12
By mechanism
P50$14,141,979 · 6
P30$1,288,182 · 1
R01$1,173,017 · 3
R21$387,846 · 1
P20$0 · 1
Top collaborators
- Soldano Ferrone2 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- John Franklin Kearney$21,145,276
- Mythreye Karthikeyan$3,883,444
- Susan L Bellis$9,674,683
- Troy D Randall$33,910,350
- James A Bonner$1,167,061
Others in their field
Top investigators on “Malignant Neoplasm Of Pancreas”
- David Heimbrook · Leidos Biomedical Research, Inc.$73,277,592
- Anirban Maitra · Johns Hopkins University$43,028,398
- Walter John Curran · Thomas Jefferson University$26,641,549
- Surinder Kumar Batra · University Of Pittsburgh At Pittsburgh$26,074,679
- Michael A Hollingsworth · University Of Nebraska Medical Center$23,837,917
- Robert E Reiter · University Of California Los Angeles$21,473,394
Research focus
Malignant Neoplasm Of PancreasFundingProgramsUniversitiesGrantFacultyCancer CenterCollaborationsCancer TherapySolid NeoplasmComprehensive Cancer CenterSuccessAwardMalignant NeoplasmsJointsTumorPublicationsCancer CellAnimal ModelAntibodiesResponseAdvisory CommitteesMemberBiology
Grant awards (47)
01 Inflammation, Immunology and Immunotherapeutics Program$26,553
P30 · FY2021 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$742,500
P30 · FY2020 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$121,913
P30 · FY2020 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$118,946
P30 · FY2019 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$8,695
P30 · FY2019 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$99,609
P30 · FY2018 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$8,650
P30 · FY2018 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$3,965
P30 · FY2018 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$2,264
P30 · FY2018 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$1,978
P30 · FY2018 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$111,105
P30 · FY2017 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$33,308
P30 · FY2016 · CA · contact PI
01 Inflammation, Immunology and Immunotherapeutics Program$8,696
P30 · FY2016 · CA · contact PI
Therapy of pancreatic cancer with 212Pb-labeled B7-H3 specific Ab and LDE225$201,799
R21 · FY2015 · CA · contact PI
UAB / UMN SPORE in Pancreatic Cancer$2,162,000
P50 · FY2014 · CA · contact PI
Career Development Program$206,433
P50 · FY2014 · CA · contact PI
Therapy of pancreatic cancer with 212Pb-labeled B7-H3 specific Ab and LDE225$186,047
R21 · FY2014 · CA · contact PI
Combined Modality Targeted Therapy of Pancreatic Cancer with Death Receptor$184,815
P50 · FY2014 · CA · contact PI
Administrative Core$131,261
P50 · FY2014 · CA · contact PI
Developmental Research Program$77,164
P50 · FY2014 · CA · contact PI
UAB / UMN SPORE in Pancreatic Cancer$2,150,500
P50 · FY2013 · CA · contact PI
Career Development Program$204,999
P50 · FY2013 · CA · contact PI
Combined Modality Targeted Therapy of Pancreatic Cancer with Death Receptor$180,680
P50 · FY2013 · CA · contact PI
Administrative Core$131,869
P50 · FY2013 · CA · contact PI
Developmental Research Program$77,587
P50 · FY2013 · CA · contact PI
UAB / UMN SPORE in Pancreatic Cancer$2,300,000
P50 · FY2012 · CA · contact PI
Career Development Program$218,327
P50 · FY2012 · CA · contact PI
Combined Modality Targeted Therapy of Pancreatic Cancer with Death Receptor$190,180
P50 · FY2012 · CA · contact PI
Administrative Core$142,092
P50 · FY2012 · CA · contact PI
Developmental Research Program$83,681
P50 · FY2012 · CA · contact PI
UAB / UMN SPORE in Pancreatic Cancer$2,185,000
P50 · FY2011 · CA · contact PI
Career Development Program$207,243
P50 · FY2011 · CA · contact PI
Combined Modality Targeted Therapy of Pancreatic Cancer with Death Receptor$178,339
P50 · FY2011 · CA · contact PI
Administrative Core$136,074
P50 · FY2011 · CA · contact PI
Developmental Research Program$80,456
P50 · FY2011 · CA · contact PI
UAB / UMN SPORE in Pancreatic Cancer$2,300,000
P50 · FY2010 · CA · contact PI
Career Development Program$217,590
P50 · FY2010 · CA · contact PI
Combined Modality Targeted Therapy of Pancreatic Cancer with Death Receptor$183,608
P50 · FY2010 · CA · contact PI
Administrative Core$126,411
P50 · FY2010 · CA · contact PI
Developmental Research Program$85,670
P50 · FY2010 · CA · contact PI
Multi-modality targeted therapy of pancreatic cancer$0
P20 · FY2003 · CA
Viral and molecular chemotherapy of malignant CNS tumors$0
P50 · FY2002 · CA
NEW BCAS FOR RADIOIMMUNOTHERAPY WITH RADIOMETALS$259,118
R01 · FY2001 · CA
EVALUATION OF CH2 DELETED HUCC49 FOR INTRAPERITONEAL RIT$226,793
R01 · FY2001 · CA
NEW BCAS FOR RADIOIMMUNOTHERAPY WITH RADIOMETALS$253,167
R01 · FY2000 · CA
EVALUATION OF CH2 DELETED HUCC49 FOR INTRAPERITONEAL RIT$221,779
R01 · FY2000 · CA
GENETIC RADIOIMMUNOTHERAPY OF PANCREATIC CANCER$212,160
R01 · FY2000 · CA